CompletedNot Applicable

Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

United States256 participantsStarted 2017-03-01

Plain-language summary

This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an educational handout) and then a questionnaire will be administered to assess knowledge and acceptability of the HPV vaccine. Subject charts will be reviewed to assess for initiation of the HPV vaccine.

Who can participate

Age range12 Years – 26 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Females ages greater than or equal to 12 years and less than or equal to 26 years
✓. Presenting to a gynecology clinic for a routine or problem visit
✓. Ability to read and write

Exclusion criteria

✕. Women ages less than or greater than 12 years or greater than 26 years
✕. Women with known cervical cancer
✕. Known pregnancy
✕. Prior initiation or completion of the HPV vaccine series

What they're measuring

HPV vaccine acceptability

Timeframe: Up to 6 months

Trial details

NCT IDNCT03337269

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-08-15

View on ClinicalTrials.gov More HPV-Related Cervical Carcinoma trials